Kennedy Giulia C 4
4 · VERACYTE, INC. · Filed Nov 15, 2022
Insider Transaction Report
Form 4
VERACYTE, INC.VCYT
Kennedy Giulia C
Chief Scientific & Med Officer
Transactions
- Exercise/Conversion
Common Stock
2022-11-11$14.34/sh+2$29→ 68,003 total - Sale
Common Stock
2022-11-11$29.34/sh−2$59→ 68,001 total - Exercise/Conversion
Stock Option (right to buy)
2022-11-11−2→ 0 totalExercise: $14.34Exp: 2024-02-18→ Common Stock (2 underlying)
Footnotes (2)
- [F1]The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 14, 2022.
- [F2]The option is fully vested.